Follow
Prof. Dr. med. Axel S. Merseburger
Prof. Dr. med. Axel S. Merseburger
Universität Lübeck
Verified email at uksh.de
Title
Cited by
Cited by
Year
EAU guidelines on renal cell carcinoma: 2014 update
B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ...
European urology 67 (5), 913-924, 2015
4751*2015
European association of urology guidelines on renal cell carcinoma: the 2019 update
B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ...
European urology 75 (5), 799-810, 2019
13552019
Apalutamide for metastatic, castration-sensitive prostate cancer
KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ...
New England Journal of Medicine 381 (1), 13-24, 2019
12682019
Renal cell carcinoma guideline
B Ljungberg, DC Hanbury, MA Kuczyk, AS Merseburger, PFA Mulders, ...
European urology 51 (6), 1502-1510, 2007
1216*2007
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines
A Stenzl, NC Cowan, M De Santis, MA Kuczyk, AS Merseburger, MJ Ribal, ...
European urology 59 (6), 1009-1018, 2011
7562011
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ...
Journal of Clinical Oncology 38 (32), 3763-3772, 2020
5942020
Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy
L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ...
European urology 69 (4), 660-673, 2016
5862016
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer
A Stenzl, NC Cowan, M De Santis, G Jakse, MA Kuczyk, AS Merseburger, ...
European urology 55 (4), 815-825, 2009
583*2009
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ...
The Lancet Oncology 22 (7), 931-945, 2021
4542021
Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 …
W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ...
Clinical Cancer Research 26 (11), 2487-2496, 2020
3532020
Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study
KN Chi, S Chowdhury, A Bjartell, BH Chung, ...
Journal of Clinical Oncology 39 (20), 2294-2303, 2021
3332021
EAU guidelines on laser technologies
TRW Herrmann, EN Liatsikos, U Nagele, O Traxer, AS Merseburger, ...
European urology 61 (4), 783-795, 2012
3042012
Impact of gender on bladder cancer incidence, staging, and prognosis
H Fajkovic, JA Halpern, EK Cha, A Bahadori, TF Chromecki, ...
World journal of urology 29, 457-463, 2011
2672011
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies
AG Anastasiadis, MP Lichy, U Nagele, MA Kuczyk, AS Merseburger, ...
European urology 50 (4), 738-749, 2006
2492006
Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer
MW Kramer, V Altieri, R Hurle, L Lusuardi, AS Merseburger, J Rassweiler, ...
European urology focus 3 (6), 567-576, 2017
2162017
Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell …
L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ...
European urology 76 (2), 151-156, 2019
2102019
Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer
T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ...
European urology 73 (3), 311-315, 2018
2062018
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc …
MW Kramer, JJ Rassweiler, J Klein, A Martov, N Baykov, L Lusuardi, ...
World journal of urology 33, 1937-1943, 2015
1952015
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised …
T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ...
The lancet oncology 23 (9), 1133-1144, 2022
1792022
EAU guidelines on robotic and single-site surgery in urology
AS Merseburger, TRW Herrmann, SF Shariat, I Kyriazis, U Nagele, ...
European urology 64 (2), 277-291, 2013
1732013
The system can't perform the operation now. Try again later.
Articles 1–20